Biologix Reinforces Its Commitment to Innovation in Pulmonary Hypertension Care at the Emirates Pulmonary Hypertension Conference 2025

Biologix reaffirmed its commitment to advancing pulmonary hypertension care through its active participation in the Emirates Pulmonary Hypertension (EPH) Conference 2025, held on 2–3 May in the UAE. The event brought together top regional and international experts to explore the latest breakthroughs in pulmonary hypertension management.

As part of its efforts to address unmet needs in PH associated with Interstitial Lung Disease (PH-ILD), Biologix hosted a scientific symposium and connected with healthcare professionals at its exhibition booth. These engagements underscored our role as a trusted partner in the field driving innovation, exchanging clinical insights, and supporting better outcomes for patients across the region.